This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Pot Stocks & ETF: Risks and Rewards
by Neena Mishra
Here is what investors need to know about risks and rewards of investing in the emerging marijuana industry.
Keurig Dr Pepper (KDP) to Acquire CORE Nutrition for $525M
by Zacks Equity Research
Keurig Dr Pepper (KDP) signs an agreement to acquire CORE Nutrition LLC - a leading bottled water and other drinks' maker - for $525 million.
Top Wall Street Stories of the Third Quarter
by Sweta Killa
We discuss some of the events that dominated the headlines in the third quarter and influenced the market.
Has the Earnings Picture Started Weakening?
by Sheraz Mian
A big part of the positive revisions over the last two quarters was due to the direct impact of the tax cuts. With that issue now behind us, the revisions trend appears to be moving back to how it has behaved over the last few years.
Why Did McDonald's (MCD) & Starbucks (SBUX) Stock Jump Friday?
by Benjamin Rains
Shares of both McDonald's (MCD) and Starbucks (SBUX) surged Friday. MCD stock jumped on the back of a dividend hike, while SBUX climbed for less obvious reasons.
Know How Beverage Stocks Will Gain From Shift to Marijuana
by Rajani Lohia
Cannabis-infused drinks have emerged as an attractive alternative to the problems of the players in the U.S. beverage space, given the health benefits it offers.
Coke Eyes Cannabis-Infused Beverages, Will Others Follow?
by Zacks Equity Research
Infused-drinks could emerge as the next big thing in the beverage market, attracting the focus of many big players.
Why Marijuana Stocks and ETF are Soaring
by Neena Mishra
Pot stocks are hot but also very volatile, here is what investors need to know
Company News For Sep 18, 2018
by Zacks Equity Research
Companies In The News are: AMZN,CGC,KO,MDP
Stock Market News For Sep 18, 2018
by Zacks Equity Research
U.S. stock markets ended sharply lower on Monday as lingering trade conflicts between the United States and China escalated once again
Is Coca-Cola's Cannabis Venture a Solution to Its Problems?
by Zacks Equity Research
Coca-Cola (KO) explores the cannabis-infused drinks market to combat the fading popularity of sugary carbonated sodas.
Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)?
by Zacks Equity Research
Sector ETF report for FSTA
Marijuana Stocks and ETF: What Investors Need to Know
by Neena Mishra
Pot stocks are hot but also very volatile, here is what investors need to know.
PepsiCo Holds Ground Despite Tough Conditions, Stock Gains 9%
by Zacks Equity Research
PepsiCO (PEP) rallies despite industry headwinds, including a shift to healthier drinks and higher costs. The company's snacking portfolio and innovation pipeline shows potential for further growth.
New Marijuana Stocks? & Earnings from ORCL and FDX | Free Lunch
by Ryan McQueeney
Ryan McQueeney touches on the trade war's latest tariff threats and a key FDA approval for Teva Pharmaceuticals. He also highlights two surprising companies which might have a chance to profit from the marijuana boom. Later, Ryan previews Oracle and FedEx's earnings reports.
FEMSA (FMX) Stock Displays Solid Momentum: Will it Sustain?
by Zacks Equity Research
FEMSA (FMX) displays momentum, backed by initiatives and a robust surprise trend. However, near-term hurdles due to soft margins and higher input costs hurt sentiment.
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Coca-Cola, Disney, BHP and Zoetis
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Coca-Cola, Disney, BHP and Zoetis
Top Analyst Reports for Berkshire Hathaway, Coca-Cola & Disney
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), Coca-Cola (KO) and Disney (DIS).
Dow 30 Stock Roundup: Coca-Cola Buys Costa, DowDuPont Earnings Impress
by Swarup Gupta
The index remained weighed down by trade tensions during a holiday-shortened week.
Coca-Cola to Acquire Costa Coffee: Consumer Staples ETFs in Focus
by Zacks Equity Research
Coca-Cola will be acquiring the U.K. coffee giant Costa Coffee, bringing the related ETFs in focus.
Coca-Cola (KO) to Expand in Coffee Space With Costa Buyout
by Zacks Equity Research
Coca-Cola (KO) expands in the burgeoning coffee segment, with $5.1-billion deal to acquire London-based coffee chain, Costa.
Coke Enters Global Coffee Market, Will Others Follow Suit?
by Zacks Equity Research
Coca-Cola's acquisition of giant coffee chain Costa gives it access to a rapidly growing coffee platform in 31 nations and further opportunities to expand.
Is Coke (KO) Stock a Buy After Costa Purchase & BodyArmor Investment?
by Benjamin Rains
Coca-Cola (KO) announced on Friday that it is set to purchase UK coffee giant Costa for $5.1 billion as it tries to expand its portfolio beyond sugary drinks. The move follows Coke's recent investment in sports drink upstart and potential Gatorade (PEP) rival BodyArmor. So, what should investors do with KO stock, which is down roughly 2% over the last 12 months, as the beverage behemoth readies itself for the future?
Coca Cola Agrees To Buy Costa Coffee
by Zacks Equity Research
Coca Cola Agrees To Buy Costa Coffee
Coke Buys U.K.'s Costa Coffee Ahead of Labor Day Weekend
by Mark Vickery
This price is a roughly 20% premium to the closing price of Costa's parent company, Whitbread, which trades on the London exchange.